全文获取类型
收费全文 | 317篇 |
免费 | 26篇 |
出版年
2023年 | 1篇 |
2022年 | 3篇 |
2021年 | 5篇 |
2020年 | 5篇 |
2019年 | 5篇 |
2018年 | 12篇 |
2017年 | 5篇 |
2016年 | 12篇 |
2015年 | 31篇 |
2014年 | 29篇 |
2013年 | 28篇 |
2012年 | 24篇 |
2011年 | 37篇 |
2010年 | 22篇 |
2009年 | 19篇 |
2008年 | 15篇 |
2007年 | 18篇 |
2006年 | 18篇 |
2005年 | 10篇 |
2004年 | 9篇 |
2003年 | 11篇 |
2002年 | 5篇 |
2001年 | 2篇 |
1999年 | 4篇 |
1998年 | 1篇 |
1997年 | 1篇 |
1995年 | 3篇 |
1993年 | 3篇 |
1991年 | 1篇 |
1986年 | 1篇 |
1985年 | 1篇 |
1979年 | 1篇 |
1978年 | 1篇 |
排序方式: 共有343条查询结果,搜索用时 15 毫秒
101.
Rieder F Lopez R Franke A Wolf A Schleder S Dirmeier A Schirbel A Rosenstiel P Dotan N Schreiber S Rogler G Klebl F 《PloS one》2011,6(5):e18172
Introduction
Anti-glycan antibodies are a promising tool for differential diagnosis and disease stratification of patients with Crohn''s disease (CD). We longitudinally assessed level and status changes of anti-glycan antibodies over time in individual CD patients as well as determinants of this phenomenon.Methods
859 serum samples derived from a cohort of 253 inflammatory bowel disease (IBD) patients (207 CD, 46 ulcerative colitis (UC)) were tested for the presence of anti-laminarin (Anti-L), anti-chitin (Anti-C), anti-chitobioside (ACCA), anti-laminaribioside (ALCA), anti-mannobioside (AMCA) and anti-Saccharomyces cerevisiae (gASCA) antibodies by ELISA. All patients had at least two and up to eleven serum samples taken during the disease course.Results
Median follow-up time for CD was 17.4 months (Interquartile range (IQR) 8.0, 31.6 months) and for UC 10.9 months (IQR 4.9, 21.0 months). In a subgroup of CD subjects marked changes in the overall immune response (quartile sum score) and levels of individual markers were observed over time. The marker status (positive versus negative) remained widely stable. Neither clinical phenotype nor NOD2 genotype was associated with the observed fluctuations. In a longitudinal analysis neither changes in disease activity nor CD behavior led to alterations in the levels of the glycan markers. The ability of the panel to discriminate CD from UC or its association with CD phenotypes remained stable during follow-up. In the serum of UC patients neither significant level nor status changes were observed.Conclusions
While the levels of anti-glycan antibodies fluctuate in a subgroup of CD patients the antibody status is widely stable over time. 相似文献102.
Soto-Cerda Braulio J. Cloutier Sylvie Gajardo Humberto A. Aravena Gabriela Quian Rocio You Frank M. 《Molecular breeding : new strategies in plant improvement》2020,40(1):1-18
Molecular Breeding - L-Ascorbic acid (AsA) is an important nutrient in non-heading Chinese cabbage (Brassica rapa ssp. chinensis). To understand the regulatory mechanism of AsA accumulation, we... 相似文献
103.
Carole D. Mitnick Molly F. Franke Michael L. Rich Felix A. Alcantara Viru Sasha C. Appleton Sidney S. Atwood Jaime N. Bayona Cesar A. Bonilla Katiuska Chalco Hamish S. F. Fraser Jennifer J. Furin Dalia Guerra Rocio M. Hurtado Keith Joseph Karim Llaro Lorena Mestanza Joia S. Mukherjee Maribel Mu?oz Eda Palacios Epifanio Sanchez Kwonjune J. Seung Sonya S. Shin Alexander Sloutsky Arielle W. Tolman Mercedes C. Becerra 《PloS one》2013,8(3)
Rationale
A better understanding of the composition of optimal treatment regimens for multidrug-resistant tuberculosis (MDR-TB) is essential for expanding universal access to effective treatment and for developing new therapies for MDR-TB. Analysis of observational data may inform the definition of an optimized regimen.Objectives
This study assessed the impact of an aggressive regimen–one containing at least five likely effective drugs, including a fluoroquinolone and injectable–on treatment outcomes in a large MDR-TB patient cohort.Methods
This was a retrospective cohort study of patients treated in a national outpatient program in Peru between 1999 and 2002. We examined the association between receiving an aggressive regimen and the rate of death.Measurements and Main Results
In total, 669 patients were treated with individualized regimens for laboratory-confirmed MDR-TB. Isolates were resistant to a mean of 5.4 (SD 1.7) drugs. Cure or completion was achieved in 66.1% (442) of patients; death occurred in 20.8% (139). Patients who received an aggressive regimen were less likely to die (crude hazard ratio [HR]: 0.62; 95% CI: 0.44,0.89), compared to those who did not receive such a regimen. This association held in analyses adjusted for comorbidities and indicators of severity (adjusted HR: 0.63; 95% CI: 0.43,0.93).Conclusions
The aggressive regimen is a robust predictor of MDR-TB treatment outcome. TB policy makers and program directors should consider this standard as they design and implement regimens for patients with drug-resistant disease. Furthermore, the aggressive regimen should be considered the standard background regimen when designing randomized trials of treatment for drug-resistant TB. 相似文献104.
105.
Angel Josabad Alonso-Castro Rocio Zapata-Bustos Fabiola DomínguezAlejandro García-Carrancá Luis A. Salazar-Olivo 《Phytomedicine》2011,18(11):926-933
Some Magnolia (Magnoliaceae) species are used for the empirical treatment of diabetes mellitus, but the antidiabetic properties of Magnolia dealbata have not yet been experimentally validated. Here we report that an ethanolic extract of Magnolia dealbata seeds (MDE) and its active principles honokiol (HK) and magnolol (MG) induced the concentration-dependent 2-NBDG uptake in murine 3T3-F442A and human subcutaneous adipocytes. In insulin-sensitive adipocytes, MDE 50 μg/ml induced the 2-NBDG uptake by 30% respect to insulin, while HK and MG, 30 μM each, did it by 50% (murine) and 40% (human). The simultaneous application of HK and MG stimulated 2-NBDG uptake by 70% in hormone-sensitive cells, on which Magnolia preparations exerted synergic effects with insulin. In insulin-resistant adipocytes, MDE, HK and MG induced 2-NBDG uptake by 57%, 80% and 96% respect to Rosiglitazone (RGZ), whereas HK and MG simultaneously applied stimulated 2-NBDG uptake more efficiently than RGZ (120%) in both murine and human adipocytes. Inhibitors of the insulin-signaling pathway abolished the glucose uptake induced by Magnolia dealbata preparations, suggesting that their antidiabetic effects are mediated by this signaling pathway. In addition, MDE, HK and MG exerted only mild to moderate proadipogenic effects on 3T3-F442A and human preadipocytes, although the combined application of HK and MG markedly increased the lipid accumulation in both cell types. In summary, Magnolia dealbata and its active principles HK and MG stimulate glucose uptake in insulin-sensitive and insulin-resistant murine and human adipocytes using the insulin signaling pathway. 相似文献
106.
Shi J Ebrik MA Yang B Garlock RJ Balan V Dale BE Pallapolu VR Lee YY Kim Y Mosier NS Ladisch MR Holtzapple MT Falls M Sierra-Ramirez R Donohoe BS Vinzant TB Elander RT Hames B Thomas S Warner RE Wyman CE 《Bioresource technology》2011,102(24):11080-11088
Accellerase 1000 cellulase, Spezyme CP cellulase, β-glucosidase, Multifect xylanase, and beta-xylosidase were evaluated for hydrolysis of pure cellulose, pure xylan, and switchgrass solids from leading pretreatments of dilute sulfuric acid, sulfur dioxide, liquid hot water, lime, soaking in aqueous ammonia, and ammonia fiber expansion. Distinctive sugar release patterns were observed from Avicel, phosphoric acid swollen cellulose (PASC), xylan, and pretreated switchgrass solids, with accumulation of significant amounts of xylooligomers during xylan hydrolysis. The strong inhibition of cellulose hydrolysis by xylooligomers could be partially attributed to the negative impact of xylooligomers on cellulase adsorption. The digestibility of pretreated switchgrass varied with pretreatment but could not be consistently correlated to xylan, lignin, or acetyl removal. Initial hydrolysis rates did correlate well with cellulase adsorption capacities for all pretreatments except lime, but more investigation is needed to relate this behavior to physical and compositional properties of pretreated switchgrass. 相似文献
107.
Utley T Haddenham D Salovich JM Zamorano R Vinson PN Lindsley CW Hopkins CR Niswender CM 《Bioorganic & medicinal chemistry letters》2011,21(23):6955-6959
Herein we report the discovery and SAR of a novel antagonist of metabotropic glutamate receptor 4 (mGlu(4)). The antagonist was discovered via a molecular switch from a closely related mGlu(4) positive allosteric modulator (PAM). This antagonist (VU0448383) displays an IC(50) value of 8.2±0.4 μM and inhibits an EC(80) glutamate response by 63.1±6.6%. 相似文献
108.
Estradiol benzoate (EB) has been one of the most widely used estrogenic agents in animal husbandry, as a way of exogenously introducing the natural hormone estradiol-17β into the animal organism. Estradiol was previously employed to induce anabolic effects or reproductive improvements in cattle. However, the employment of EB in European countries has been permanently forbidden by Directive 2008/97/EC to guarantee consumers’ health. Despite this prohibition, the control of estradiol-17β and its esters continues to be a difficult task for residue-monitoring plans in European Communities because official analyses of natural thresholds for hormones in cattle have not yet been established, leading to a lack of confirmation for any exogenous administration of natural hormones. Several researchers have worked on excretion profiles of metabolites, variation in specific hormonal ratios and metabolomic fingerprints after hormonal treatments. This research focuses on the possible existence of disturbances in the serum profile of animals treated with EB in terms of steroid sex hormones (androgens, oestrogens and progestogens), by investigating the serum levels of several of these hormones. The serum samples were collected from three groups of cows: one treated with an intramuscular injection of EB, one treated with a combination of intravaginal EB and progesterone and a control (non-treated) group. The samples have been analysed by a validated high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) method, and 17 natural hormones were identified and quantified. Subsequently, data from the serum profiles were submitted for statistic and multivariate analysis, and it was possible to observe a manifest variation between animal groups. The obtained results can help in the development of a viable screening tool for monitoring purposes in cattle. 相似文献
109.
110.
Sinusoidal and apical transporters are responsible for the uptake and biliary elimination of many compounds by hepatocytes.
Few in vitro models are however available for analyzing such functions. The expression and bile-acid inducibility of 13 transporters
and two nuclear receptors were investigated in the new rat polarized lines, Can 3−1 and Can 10, and in their unpolarized parent,
Fao. The relative abundance of mRNA, the protein level, and their localization were examined by real-time quantitative PCR,
Western blotting, immunofluorescence, and confocal microscopy. Compared with rat liver, mRNA levels of Fao cells were: negligible
for Bsep/Abcb11; lower for the uptake transporters Ntcp and Oatps; similar for SHP, FXR, and Bcrp/Abcg2; and higher (four–fold
to 160-fold) for the efflux pumps Mdr1b/Abcb1b, Mdr2/Abcb4, Mrp1/Abcc1, Mrp2/Abcc2, Mrp3/Abcc3, Abcg5, and Abcg8. This profile
was mostly maintained (and improved for Bsep) in Can 10. Some transporters were less well expressed in Can 3−1. In both lines,
sinusoidal (Ntcp, Mrp3) and canalicular transporters (Mdr-P-glycoproteins detected with C219 antibody, Mrp2) were localized
at their correct poles. Bile-acid effects on polarity and mRNA levels of transporters were analyzed after a 6-day treatment
with 50 μM taurocholic, chenodeoxycholic (CDCA), or ursodeoxycholic acid (UDCA). No polarization of Fao cells was induced;
Can 10 and Can 3−1 polarity was maintained. CDCA and UDCA induced marked enhancement of the volume of Can 10 bile canaliculi.
CDCA upregulated Bsep, Mdr2, SHP, Mdr1b, and Oatp2/1a4 in Can 10 (two- to seven-fold) and in Fao cells. Thus, Can 10 constitutes
an attractive polarized model for studying vectorial hepatobiliary transport of endogenous and xenobiotic cholephilic compounds.
This work was supported by a grant from Egide (PAI Picasso) and the Acción Integrada Hispano-Francesa (HF2003-0089). This
research group is part of the Network for Cooperative Research on Membrane Transport Proteins (REIT), co-funded by the Ministerio
de Educación y Ciencia, Spain and the European Regional Development Fund (ERDF; grant BFU2005-24983-E/BFI) and belongs to
the “Centro de Investigación Biomédica en Red” for Hepatology and Gastroenterology Research (CIBERehd), Instituto de Salud
Carlos III, Spain. 相似文献